XML 35 R19.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stockholders’ Equity
 12 Months Ended
Dec. 31, 2024
Equity [Abstract]  
Stockholders' Equity
10. Stockholders’ Equity
Preferred Stock
As of December 31, 2024 and 2023, the Company had authorized 10,000,000 shares of undesignated preferred stock, par value $0.001, of which no shares were issued and outstanding.
Common Stock
As of December 31, 2024 and 2023, the Company had authorized 100,000,000 shares of Class A common stock, par value $0.001 per share and 20,000,000 shares of Class B common stock, par value $0.001 per share.
Shares of Class B common stock are convertible into shares of Class A common stock on a 1:1 basis upon the stockholder’s voluntary written notice to the Company’s transfer agent or a transfer by the stockholder, subject to limited exceptions for transfers for estate planning purposes.
Voting Rights
The holders of Class A common stock and Class B common stock have identical rights, except that holders of Class A voting common stock are entitled to one vote per share of Class A common stock and holder of Class B common stock are entitled to ten votes per share of Class B common stock.
Dividends
Any dividends or distributions paid or payable to the holders of shares of Class A common stock and Class B common stock shall be paid pro-rata, on an equal priority. During the years ended December 31, 2024, 2023 and 2022, no dividends were declared. Dividend payments are not subject to restriction.
Reserved Shares
The Company had reserved shares of Class A common stock for issuance under stock-based award agreements as follows:
As of December 31,
20242023
Stock options issued and outstanding79,238 97,480 
Nonvested restricted stock units issued and outstanding4,364,486 5,066,159 
Stock-based awards available for grant under the 2017 Plan1,878,290 2,330,616 
Total6,322,014 7,494,255